Peak Financial Management, Inc. Johnson & Johnson Transaction History

Peak Financial Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$155.22 - $162.74 $199,612 - $209,283	1,286 New	1,286 $203,000
Q3 2023 Oct 24, 2023	SELL	$155.75 - $174.48 $7,164 - $8,026	-46 Reduced 2.8%	1,599 $249,000
Q2 2023 Jul 26, 2023	BUY	$154.35 - $166.11 $154 - $166	1 Added 0.06%	1,645 $272,000
Q2 2022 Jul 29, 2022	SELL	$168.19 - $186.01 $7,904 - $8,742	-47 Reduced 2.78%	1,644 $292,000
Q4 2021 Jan 27, 2022	BUY	$155.93 - $173.01 $31,030 - $34,428	199 Added 13.34%	1,691 $289,000
Q3 2021 Oct 19, 2021	SELL	$161.5 - $179.47 $5,491 - $6,101	-34 Reduced 2.23%	1,492 $241,000
Q2 2021 Aug 04, 2021	BUY	$159.48 - $171.07 $13,236 - $14,198	83 Added 5.75%	1,526 $251,000
Q1 2021 Apr 29, 2021	BUY	$153.07 - $170.48 $220,880 - $246,002	1,443 New	1,443 $237,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $421B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Peak Financial Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Peak Financial Management, Inc. with notifications on news.